KENYA BIOLOGICS LTD. IS ONE OF THE KEY PLAYER DEVELOPING, MANUFACTURING AND COMMERCIALIZING BIOPESTICIDES FOR THE KENYAN MARKET.
ÉLÉPHANT VERT, an industrial player of the biological crop protection market in Europe and Africa, announces its acquisition of Kenya Biologics Ltd., a Kenyan pioneering player in biopesticides. Kenya Biologics Ltd. develops, manufactures and sells biological pest control products targeting both large scale farms growing flowers and vegetables for export markets and the smallholder farmers growing crops for own use and for the local market. Their product range consists of biopesticides, other biologicals, pheromones, plant extracts and plant health products. Based in Kenol (Kenya), the company was founded in 2007 and intends to reach over 50,000 farmers in the next five years with its own sales force.
ÉLÉPHANT VERT, a Swiss group that strives for healthy and sustainable agriculture, with the support of the Antenna Foundation, has over 360 employees in five countries in Africa and in Europe and develops and markets organic amendments, biofertilizers, biostimulants and 100% natural biopesticides made in four production units.
This acquisition is the outcome of a long and productive cooperation between ÉLÉPHANT VERT and Kenya Biologics Ltd. which started three years ago with a distribution agreement of Helitec, a biological pesticide, in North and Western Africa and a first equity participation of ÉLÉPHANT VERT in order to achieve a new Helitec production plant and support the ambitious project of Kenya Biologics Ltd.
By acquiring Kenya Biologics Ltd., ÉLÉPHANT VERT’s ambition is to consolidate its geographical presence in Africa, thus allowing to combine productivity increase with sustainable development. “Kenya Biologics Ltd.’s acquisition is a new step to extend ÉLÉPHANT VERT geographical reach and our presence on the Kenyan agricultural market. We are now well positioned to further grow bioinputs – with a specific focus on the production of biopesticides – and innovative services, and become a major agricultural hub for African farmers”, says Sébastien Couasnet, CEO of ÉLÉPHANT VERT.
“Kenya Biologics Ltd. is excited to have ÉLÉPHANT VERT as its new owner. Our concept of focusing on the African farmer and its specific problems, has proven successful through our customer’s loyalty and our rapid growth. For Kenya Biologics Ltd. to make the next step in growth, we need access to a variety of resources. Besides access to finance we will be able to leverage on ÉLÉPHANT VERT’s specific Research and Development capabilities, manufacturing expertise and their large distribution network. Both our companies are dedicated to make farming more sustainable, while at the same time help farmers increase 2 their yields and revenue. I believe that our companies are a perfect fit to achieve these ambitious goals.” adds Christian Kolenberg, CEO of Kenya Biologics Ltd.